Qualitative study of primary care clinicians’ views on point-of-care testing for C-reactive protein for acute respiratory tract infections in family medicine

Abstract

ObjectiveTo explore clinicians views of the barriers and facilitators to use of C-reactive protein (CRP) point-of-care tests (POCT) in US family medicine clinics for the management of acute respiratory tract infections (ARTIs) in adults.SettingFive family medicine clinics across two US states.Participants30 clinicians including 18 physicians, 9 physician residents, 2 physician assistants and 1 nurse practitioner, took part in the study.DesignA qualitative study using a grounded theory approach to thematically analyse focus group interviews.ResultsThese clinicians had limited access to diagnostic tests for patients with ARTI, and very little knowledge of CRP POCT. Three major themes were identified and included the potential clinical role of CRP POCT, concerns related to implementing CRP POCT and evidence needed prior to wider adoption in family medicine. Clinicians believed CRP POCT could support decision-making for some presentations of ARTIs and patient populations when used in conjunction with clinical criteria. Clinicians had concerns about possible overuse and inaccuracy of CRP POCT which they believed might increase antibiotic prescribing rates. Other concerns identified included integration of the test with clinic workflows and cost-effectiveness.ConclusionsClinicians stand at the forefront of antibiotic stewardship efforts, but have few diagnostic tests to help them confidently manage ARTIs. CRP POCT may facilitate some aspects of clinical practice. Incorporating CRP POCT with clinical guidelines may strengthen utility of this test, when there is diagnostic uncertainty.

C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT

“…Clinicians generally have positive views about using CRP POCTs to manage LRTIs, and feel that they provide an indication of disease severity, help manage patient expectations and increase their confidence in antibiotic-prescribing decisions. 67,102,103 Previous studies have also found similar concerns about the costs and implementation of CRP POCTs in the management of LRTIs in NHS primary care services. 68 Our health economic evaluation identified reduced antibiotic costs at the initial consultation but no significant differences in the total incremental cost for all causes at 4 weeks or 6 months, or if only COPD-related health-care costs were considered in the analysis.…”

Host-Based Diagnostics for Acute Respiratory Infections

“…This feeling is echoed by primary care physicians, who believe that point-of-care CRP testing can be helpful in supporting decision-making when combined with clinical criteria in ARIs but that care must be taken not to rely too heavily on the test. 16 Procalcitonin (PCT), the pro-hormone of calcitonin, is an acute inflammatory marker that tends to be higher in bacterial infections compared with viral infections, fungal infections, or noninfectious inflammatory responses. 17e19 It is stable in serum with a long half-life, making it a good candidate for measurement in a clinical setting.…”

Reducing inappropriate antibiotic prescribing for children in primary care: a cluster randomised controlled trial of two interventions

“…11,12 Also, having an observable test result to share might reassure patients that clinicians are making appropriate treatment decisions. 13 Overprescribing can also be attributed to physicians' failure to cope with parental concern. When physicians engage in reassuring worried parents too promptly, parents can feel misunderstood and restate their worries to get the physician's attention.…”